Press release
Strong Growth Ahead: Geriatric Medicines Market Size To Grow At Arecord 16.2% Cagr By 2029
Geriatric Medicines Market
How Big Is the Geriatric Medicines Market Size Expected to Be by 2034?
The market for geriatric medicines has seen a swift expansion in recent times. It is projected to expand from $1227.91 billion in 2024 to $1430.84 billion in 2025, with a compound annual growth rate (CAGR) of 16.5%. This surge during the historic period can be linked to a rising incidence of stroke and chronic diseases, an increase in cardiovascular diseases, enhanced government backing, and a greater focus on personalized medicine.
The market for geriatric medicines is forecasted to experience a swift expansion in the upcoming years, with its size projected to reach $2604.86 billion in 2029 at a compound annual growth rate (CAGR) of 16.2%. The anticipated growth during this period can be linked to the escalating occurrence of health conditions associated with aging, growing elderly populace, increased healthcare spending, an upsurge in geriatric medicine, and rising cases of hypertension. The forecast period will witness major trends like the adoption of digital pills and health monitoring wearables, the creation of approaches and instruments to safely handle multiple medications, breakthroughs in stem cell and gene therapy, broadened adoption of telehealth platforms, and advancements in the early detection and prevention of diseases related to aging.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20817
What Are the Emerging Segments Within the Geriatric Medicines Market?
The geriatric medicines market covered in this report is segmented -
1) By Therapeutics: Analgesics, Antihypertensive, Statins, Proton Pump Inhibitors, Anticoagulant, Antipsychotic, Other Therapeutics
2) By Condition: Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, Respiratory, Other Conditions
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Analgesics: Non-Opioid Analgesics (Acetaminophen, NSAIDs), Opioid Analgesics (Morphine, Oxycodone), Topical Analgesics (Lidocaine Patches)
2) By Antihypertensive: Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Beta-Blockers, Calcium Channel Blockers, Diuretics, Alpha-Blockers
3) By Statins: Atorvastatin, Simvastatin, Rosuvastatin, Pravastatin, Lovastatin
4) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole
5) By Anticoagulant: Warfarin, Direct Oral Anticoagulants (DOACs): Dabigatran, Rivaroxaban, Apixaban, Heparin
6) By Antipsychotic: Atypical Antipsychotics, Typical Antipsychotics
7) By Other Therapeutics: Antidepressants (SSRIs, SNRIs), Antidiabetic Medications (Insulin, Metformin), Anticonvulsants, Anti-Inflammatory Drugs (Corticosteroids), Cognitive Enhancers (Donepezil, Memantine)
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20817&type=smp
What Long-Term Drivers Are Shaping Geriatric Medicines Market Trends?
The geriatric medicines market is likely to see an upward trajectory due to the growing prevalence of age-related health issues. As people age, they experience health problems that become more frequent or intense, driven by factors such as longer lifespans, advancements in healthcare, and an aging population. Geriatric medicines play a crucial role in managing these age-related health conditions, providing special treatments designed specifically for older adults, hence enhancing their healthcare outcomes and the quality of life. The Office for Health Improvement and Disparities (OHID), a government institution from the UK, published a report in March 2023 indicating that in 2022, 17.6% of individuals aged 16 and above reported having a persistent musculoskeletal (MSK) condition such as arthritis or chronic back or joint problems. This was a rise from the prior year's prevalence of 17.0%. Consequently, the escalating prevalence of age-associated health issues fuels the expansion of the geriatric medicines market.
Who Are the Top Competitors in Key Geriatric Medicines Market Segments?
Major companies operating in the geriatric medicines market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Regeneron Pharmaceuticals Inc., Macleods Pharmaceuticals Ltd., Apotex Inc., Intas Pharmaceuticals Limited, Dr. Reddy's Laboratories, Lupin Limited, Biocon Limited, Torrent Pharmaceuticals Ltd., Endo Pharmaceuticals Inc.
What Actigraphy Devices Market Trends Are Gaining Traction Across Different Segments?
Leading organizations in the geriatric medicines sector are turning their focus toward the creation of innovative diabetes treatments aimed at satisfying the increasing need for efficient solutions among the fast-ageing population. Unlike traditional approaches, these novel diabetes therapies emphasize enhancing diabetes control or introducing potential cures, thereby resulting in improved effectiveness, safety, and patient results. For instance, Akums Drugs & Pharmaceuticals Ltd., a pharmaceutical contract manufacturing corporation based in India, in August 2023, introduced a unique combination therapy made up of Vildagliptin SR and Metformin SR. This state-of-the-art compound, particularly designed for managing Type 2 diabetes in aged patients, promises potent glycemic control. The therapy also mitigates key issues such as hypoglycemia and weight increase, which are particularly significant for this age group. The combination therapy enhances insulin release and effectively lowers blood sugar levels by combining the actions of both drugs, therefore guaranteeing safety and effectiveness. The new product has officially received approval from the Drug Controller General of India (DCGI).
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/geriatric-medicines-global-market-report
Which Regions Are Becoming Hubs for Geriatric Medicines Market Innovation?
North America was the largest region in the geriatric medicines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the geriatric medicines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Geriatric Medicines Market?
2. What is the CAGR expected in the Geriatric Medicines Market?
3. What Are the Key Innovations Transforming the Geriatric Medicines Industry?
4. Which Region Is Leading the Geriatric Medicines Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Strong Growth Ahead: Geriatric Medicines Market Size To Grow At Arecord 16.2% Cagr By 2029 here
News-ID: 4067125 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Geriatric
Geriatric Care Services Market Report 2024 - Geriatric Care Services Market Size …
"The Business Research Company recently released a comprehensive report on the Global Geriatric Care Services Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The geriatric care services…
Rising Geriatric Population Proliferates Precision Cardiology Industry
The precision cardiology market generates $1,011.5 million in revenue in 2021, and it is projected to grow at a rate of 12.8% from 2021 to 2030, to capture $2,998.4 million in revenue in 2030. It is ascribed to the declining cost of the sequencing methods, and rising awareness of early screening of cardiovascular diseases due to their increasing prevalence.
Market Overview@ https://www.psmarketresearch.com/market-analysis/precision-cardiology-market
In addition, the industry is progressing with technological advancements in…
Geriatric Care Devices Market 2021 | Detailed Report
According to Market Study Report, Geriatric Care Devices Market provides a comprehensive analysis of the Geriatric Care Devices Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of Geriatric Care Devices Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5042670
The report provides a…
Soaring Geriatric Demographic & Sophisticated Technology Buttress Geriatric Medi …
Governments’ relentless pitch for all-round assistance for geriatric people along with technological advancements aimed at ameliorating medical assistance has underpinned the geriatric medicines market. One of the insurance programs in the United States named as the Federal Long Term Care Insurance Program has aptly incorporated near-to-full medical cost of the Americans. Factors such as longer life-expectancy, aging demographic, swelled awareness and adoption of sophisticated therapeutics are prophesized to propel the…
Consistent Rise in Geriatric Population is Expected to Stimulate the Growth of G …
Geriatric population is more susceptible to chronic diseases such as heart problems, joint disorders and others. Therefore, this population group needs regular use of the medicines to prevent the disease conditions. The use of complementary and alternative medicines is increasing among the geriatric population globally due to the fact that CAMs decreases the risk of adverse reactions and drug interactions.
Complementary and alternative medicines include products such as dietary medicine…
Consistent Rise in Geriatric Population is Expected to Stimulate Geriatric Compl …
Geriatric Complementary and Alternative Medicines (CAM) Market: Overview
Geriatric population is more susceptible to chronic diseases such as heart problems, joint disorders and others. Therefore, this population group needs regular use of the medicines to prevent the disease conditions. The use of complementary and alternative medicines is increasing among the geriatric population globally due to the fact that CAMs decreases the risk of adverse reactions and drug interactions.
Browse to unlock…
